Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye leaves a comment following OncoZenge’s announcement of a collaboration with UCLA, marking an important first step toward a potential future US market entry for BupiZenge.</li><li>We view this initiative as a strategically sound move that broadens the scope of the program beyond Europe, while also providing valuable patient insights to support future regulatory and clinical planning in the US.</li></ul>

Redeye leaves a comment following OncoZenge’s announcement of a collaboration with UCLA, marking an important first step toward a potential future US market entry for BupiZenge.We view this initiative as a strategically sound move that broadens the scope of the program beyond Europe, while also providing valuable patient insights to support future regulatory and clinical planning in the US.

Oncozenge

OncoZenge: Partnership with UCLA